IncobotulinumtoxinA for the Treatment of Glabella and Forehead Dynamic Lines: A Real-Life Longitudinal Case Series

IncobotulinumtoxinA for the Treatment of Glabella and Forehead Dynamic Lines: A Real-Life Longitudinal Case Series

Ana Lucia Gonzaga da Cunha,1 Rossana Vasconcelos,2 David Di Sessa,3 Gabriel Sampaio,4 Pitila Ramalhoto,5 Bruno F Zampieri,6 Bárbara S Deus,7 Suyan Vasconcelos,8 Talitha Bellote,9 Juiano Carvalho,10 Giseli Petrone,5 Vinicius Figueredo,11 Gustavo Limongi Moreira3 1Clínica Skinline, Santo André, SP, Br...

Full description

Bibliographic Details
Main Authors:	da Cunha ALG, Vasconcelos R, Di Sessa D, Sampaio G, Ramalhoto P, Zampieri BF, Deus BS, Vasconcelos S, Bellote T, Carvalho J, Petrone G, Figueredo V, Limongi Moreira G
Format:	Article
Language:	English
Published:	Dove Medical Press 2023-03-01
Series:	Clinical, Cosmetic and Investigational Dermatology
Subjects:	incobotulinumtoxina botulinum toxin injection technique one21 dynamic wrinkles upper face xeomin.
Online Access:	https://www.dovepress.com/incobotulinumtoxina-for-the-treatment-of-glabella-and-forehead-dynamic-peer-reviewed-fulltext-article-CCID

Similar Items

Tolerability and Efficacy of Customized IncobotulinumtoxinA Injections for Essential Tremor: A Randomized, Double-Blind, Placebo-Controlled Study
by: Mandar Jog, et al.
Published: (2020-12-01)

One21: A Novel, Customizable Injection Protocol for Treatment of the Forehead with IncobotulinumtoxinA
by: de Sanctis Pecora C
Published: (2020-02-01)

Botulinum toxin A (IncobotulinumtoxinA) and pneumoperitoneum image-guided for hernia repair with loss of dominance
by: Sergio E. López-Juárez, et al.
Published: (2023-01-01)

Tailored botulinum toxin type A injections in aesthetic medicine: consensus panel recommendations for treating the forehead based on individual facial anatomy and muscle tone
by: Anido J, et al.
Published: (2017-10-01)

Prospective evaluation of incobotulinumtoxinA in the management of the masseter using two different injection techniques
by: Nikolis A, et al.
Published: (2018-07-01)

Outcomes of IncobotulinumtoxinA Injection on Myalgia and Arthralgia in Patients Undergoing Temporomandibular Joint Arthroscopy: A Randomized Controlled Trial
by: David Faustino Ângelo, et al.
Published: (2023-06-01)

Cost-Effectiveness of IncobotulinumtoxinA in the Treatment of Sialorrhea in Patients with Various Neurological Conditions
by: Koji Makino, et al.
Published: (2020-03-01)

Efficacy and Safety of IncobotulinumtoxinA in the Treatment of Lower Limb Spasticity in Japanese Subjects
by: Yoshihisa Masakado, et al.
Published: (2022-03-01)

Pain Reduction in Cervical Dystonia Following Treatment with IncobotulinumtoxinA: A Pooled Analysis
by: Alberto Albanese, et al.
Published: (2023-05-01)

Effects of Ultrasound-Guided Administration of Botulinum Toxin (IncobotulinumtoxinA) in Patients with Lateral Epicondylitis
by: Antonio Galván Ruiz, et al.
Published: (2019-01-01)

Quality of life in subjects with upper- and lower-limb spasticity treated with incobotulinumtoxinA
by: Klemens Fheodoroff, et al.
Published: (2020-03-01)

Pain Reduction in Adults with Limb Spasticity Following Treatment with IncobotulinumtoxinA: A Pooled Analysis
by: Jörg Wissel, et al.
Published: (2021-12-01)

IncobotulinumtoxinA in the treatment of sialorrhea in patients with infantile cerebral palsy
by: A. L. Kurenkov, et al.
Published: (2021-08-01)

Safety Profile and Lack of Immunogenicity of IncobotulinumtoxinA in Pediatric Spasticity and Sialorrhea: A Pooled Analysis
by: Steffen Berweck, et al.
Published: (2022-08-01)

Post hoc analysis of the improvement in shoulder spasticity and safety observed following treatment with incobotulinumtoxinA
by: Jörg Wissel, et al.

Russian consensus on the use of incobotulinumtoxinA in children with cerebral palsy for the treatment of spasticity and sialorrhea
by: A. L. Kurenkov, et al.
Published: (2022-04-01)

Real-World Six-Year National Cost-Minimization Analysis of IncobotulinumtoxinA and OnabotulinumtoxinA in the VA/DoD Healthcare Systems
by: Kazerooni R, et al.
Published: (2021-06-01)

Improvement in Quality-of-Life-Related Outcomes Following Treatment with IncobotulinumtoxinA in Adults with Limb Spasticity: A Pooled Analysis
by: Franco Molteni, et al.
Published: (2023-12-01)

Pooled Safety Analysis of IncobotulinumtoxinA in the Treatment of Neurological Disorders in Adults
by: Wolfgang H. Jost, et al.
Published: (2023-05-01)

Efficacy and safety of two incobotulinumtoxinA injection intervals in cervical dystonia patients with inadequate benefit from standard injection intervals of botulinum toxin: Phase 4, open-label, randomized, noninferiority study
by: Cynthia Comella, et al.
Published: (2022-01-01)

Characterization of SNARE Cleavage Products Generated by Formulated Botulinum Neurotoxin Type-A Drug Products
by: Jack Xie, et al.
Published: (2010-08-01)

A novel technique of botulinum toxin injection around skull sutures for chronic migraine: A randomized controlled clinical trial
by: Helia Hemasian, et al.
Published: (2022-01-01)

Clinical Improvement After Treatment With IncobotulinumtoxinA (XEOMIN®) in Patients With Cervical Dystonia Resistant to Botulinum Toxin Preparations Containing Complexing Proteins
by: Harald Hefter, et al.
Published: (2021-02-01)

Botulinum toxin therapy (Incobotulinumtoxin А) in the complex rehabilitation of adolescents with cerebral palsy (clinical case)
by: E. V. Kostenko, et al.
Published: (2018-05-01)

Functional influence of botulinum neurotoxin type A treatment (Xeomin®) of multifocal upper and lower limb spasticity on chronic hemiparetic gait
by: Maurizio Falso, et al.
Published: (2012-05-01)

Intramuscular <i>versus</i> intradermal botulinum toxin for forehead wrinkles: a review of side effects and efficacy
by: Mohammed Almashali, et al.
Published: (2023-08-01)

IncobotulinumtoxinA Injection for Treating Children with Idiopathic Toe Walking: A Retrospective Efficacy and Safety Study
by: Mirko Filippetti, et al.
Published: (2022-11-01)

Treatment for spasticity after stroke
by: S. E. Khatkova
Published: (2010-09-01)

“Appropriate Treatment” and Therapeutic Window in Spasticity Treatment with IncobotulinumtoxinA: From 100 to 1000 Units
by: Giancarlo Ianieri, et al.
Published: (2018-03-01)

A case of segmental dystonia with mental/psychic nonmotor disorders
by: V. A. Tolmacheva, et al.
Published: (2019-11-01)

Monocentric Prospective Study into the Sustained Effect of Incobotulinumtoxin A (XEOMIN®) Botulinum Toxin in Chronic Refractory Migraine
by: Ioana Ion, et al.
Published: (2018-06-01)

Treatment of Vestibulodynia with Submucosal Injections of IncobotulinumtoxinA into Targeted Painful Points: An Open-Label Exploratory Study
by: Paula Villa-Muñoz, et al.
Published: (2023-07-01)

Real-World Dosing of OnabotulinumtoxinA and IncobotulinumtoxinA for Cervical Dystonia and Blepharospasm: Results from TRUDOSE and TRUDOSE II
by: Ruth Kent, et al.
Published: (2021-07-01)

Botulinum neurotoxin type A in the interdisciplinary treatment of sialorrhea in adults and children—update and practice recommendations
by: Wolfgang H. Jost, et al.
Published: (2023-12-01)

Optimizing Botulinum Toxin A Administration for Forehead Wrinkles: Introducing the Lines and Dots (LADs) Technique and a Predictive Dosage Model
by: Kamal Alhallak
Published: (2024-02-01)

Efficacy of Intra-Articular Injection of Botulinum Toxin Type A (IncobotulinumtoxinA) in Temporomandibular Joint Osteoarthritis: A Three-Arm Controlled Trial in Rats
by: Marie Béret, et al.
Published: (2023-04-01)

Factors Influencing the Surgical Decision in Dystonia Patients Referred for Deep Brain Stimulation
by: Carolina Gorodetsky, et al.
Published: (2021-07-01)

Considerations on patient-related outcomes with the use of botulinum toxins: is switching products safe?
by: Fraint A, et al.
Published: (2016-02-01)

High Levels of Physical Activity Reduce the Esthetic Durability of Botulinum Toxin Type A: A Controlled Single-Blind Clinical Trial
by: Omar Neves Morhy, et al.
Published: (2023-07-01)

Office‐based facial plastics procedures: Neuromodulators
by: Andrew J. Johnson, et al.
Published: (2023-09-01)